Redcliffe Labs Acquires Megavision Diagnostics to Strengthen Integrated Diagnostics in Pune

Redcliffe Labs Expands Radiology and Advanced Imaging Capabilities

Redcliffe Labs acquired Pune-based Megavision Diagnostics Center, strengthening its radiology and advanced imaging capabilities and accelerating its transition towards an integrated diagnostics platform.

The acquisition brought two MRI-equipped diagnostic centers in Pimpri-Chinchwad, Pune, into the Redcliffe Labs network, complementing its established pathology and diagnostic services.

With the acquisition, Redcliffe Labs strengthened its ability to bring pathology and radiology together under one integrated diagnostics ecosystem, enabling a more comprehensive range of diagnostic services for patients.

What Did Redcliffe Labs Acquire?

Megavision Diagnostics Center has served patients and clinicians in Pune's Pimpri-Chinchwad region for more than two decades.

The network operates two diagnostic centers in Pimpri and Nigdi, with capabilities across advanced medical imaging and diagnostic services.

The acquisition added imaging capabilities including:

• MRI
• CT scans
• Sonography
• ECG
• Mammography
• Other radiology and diagnostic services

The two centers are equipped with MRI infrastructure and add advanced imaging capacity to Redcliffe Labs' existing pathology-led diagnostics network.

Why Did Redcliffe Labs Acquire Megavision Diagnostics?

The acquisition was an important step in Redcliffe Labs' strategy to build an integrated diagnostics platform combining pathology, radiology and advanced imaging.

Redcliffe Labs has built significant capabilities across pathology, laboratory diagnostics, and home sample collection. The acquisition of Megavision expanded this ecosystem by adding established radiology infrastructure and expertise.

By integrating existing advanced imaging infrastructure and regional clinical expertise, Redcliffe Labs strengthened its diagnostic capabilities in Pune and Western India.

What Does Megavision Add to Redcliffe Labs?

Megavision brought more than imaging infrastructure to the Redcliffe Labs network.

With over two decades of presence in Pune, Megavision had built strong relationships with patients and clinicians in the region, along with established expertise in diagnostic imaging.

Following the acquisition, Dr. Kedar Prabhakar Bhate, founder of Megavision Diagnostics, continued to lead the operations, working with the Redcliffe Clinical Board to strengthen radiology services and expand integrated diagnostics in Pune and Western India.

Redcliffe Labs also retained Megavision's entire workforce, supporting continuity of patient care and services following the acquisition.

From Pathology to Integrated Diagnostics

The acquisition strengthened Redcliffe Labs' ability to bring together:

Pathology + Radiology + Advanced Imaging + Digital Diagnostics

This integrated approach supports a more comprehensive diagnostic journey and better-informed clinical decision-making.

Why Is Integrated Diagnostics Important?

Modern healthcare often requires more than one type of diagnostic investigation.

Blood tests and other pathology investigations provide information about biochemical, metabolic, and cellular health, while radiology and advanced imaging help doctors visualize structures and abnormalities inside the body.

Bringing these capabilities together can create a more connected diagnostic experience for patients and healthcare providers.

Redcliffe Labs' integrated diagnostics strategy brings laboratory diagnostics, radiology, advanced imaging, technology, and clinical expertise together within one ecosystem.

What Does the Acquisition Mean for Patients in Pune?

The acquisition strengthens access to advanced diagnostic imaging and pathology services within a connected diagnostics network in Pune.

For patients, an integrated diagnostics model can provide easier access to multiple diagnostic modalities and a more connected healthcare experience.

Adding Megavision's imaging capabilities also strengthens Redcliffe Labs' presence in Pimpri-Chinchwad and Western India.

Redcliffe Labs–Megavision Acquisition: Key Highlights

Key Highlight	Details
Acquirer	Redcliffe Labs
Acquired company	Megavision Diagnostics Center
Location	Pune, Maharashtra
Diagnostic centers added	Two centers in Pimpri-Chinchwad
Key capability	MRI and advanced diagnostic imaging
Additional services	CT, sonography, ECG, mammography and other diagnostics
Megavision legacy	More than two decades in the region
Workforce	Retained by Redcliffe Labs
Leadership	Dr. Kedar Prabhakar Bhate continued to lead operations
Strategic objective	Strengthen integrated diagnostics and radiology capabilities

A Step Towards the Future of Integrated Diagnostics

The acquisition of Megavision Diagnostics marked another step in Redcliffe Labs' evolution from a pathology-focused diagnostics provider towards a more integrated diagnostics platform combining pathology and radiology.

By bringing together advanced imaging capabilities, laboratory diagnostics, technology and regional clinical expertise, Redcliffe Labs continues to strengthen its ability to deliver comprehensive, accessible and connected diagnostic services.

The Megavision acquisition also reinforces Redcliffe Labs' long-term focus on expanding its integrated diagnostics presence across Pune and Western India through strategic growth.

Frequently Asked Questions

What is the Redcliffe Labs and Megavision Diagnostics acquisition?

Redcliffe Labs acquired Pune-based Megavision Diagnostics Center, strengthening its radiology and advanced imaging capabilities and adding two MRI-equipped centers in Pimpri-Chinchwad.

When did Redcliffe Labs acquire Megavision Diagnostics?

Redcliffe Labs completed the acquisition in August 2026, strengthening its presence in radiology and advanced diagnostics in Pune.

Where is Megavision Diagnostics located?

Megavision Diagnostics operates two diagnostic centers in Pimpri and Nigdi in Pune's Pimpri-Chinchwad region.

What services did Megavision add to Redcliffe Labs?

Megavision strengthened Redcliffe Labs' radiology and advanced imaging capabilities, including MRI, CT scans, sonography, ECG, and mammography.

Why did Redcliffe Labs acquire Megavision Diagnostics?

The acquisition strengthened Redcliffe Labs' strategy to build an integrated diagnostics platform combining pathology and radiology, while expanding its presence in Pune and Western India.

Will Megavision's team continue with Redcliffe Labs?

Yes. Redcliffe Labs retained Megavision's workforce, while Dr. Kedar Prabhakar Bhate continued to lead operations.

What does the Megavision acquisition mean for Redcliffe Labs?

The acquisition expanded Redcliffe Labs' capabilities beyond pathology by adding established radiology and advanced imaging infrastructure, supporting its broader vision of building an integrated diagnostics ecosystem.